Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Combination Details

General Information of the Combination (ID: C13798)
Name Epigallocatechin gallate   NP Info  + N-(4-hydroxyphenyl) retinamide   Drug Info 
Structure +
Disease
Adrenocortical carcinoma [ICD-11: 2D11]
Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Enhancing Drug Efficacy by This Combination
                 Augmenting Drug Sensitivity     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [1]
                    Molecule(s)
                    Regulation
Down-regulation Expression microRNA 106b  Molecule Info 
Pathway MAP
Up-regulation Expression microRNA 34a  Molecule Info 
Pathway MAP
Up-regulation Expression microRNA 7-1  Molecule Info 
Pathway MAP
Down-regulation Expression microRNA 92b  Molecule Info 
Pathway MAP
Down-regulation Expression microRNA 93  Molecule Info 
Pathway MAP
Up-regulation Expression microRNA 99a  Molecule Info 
Pathway MAP
                    In-vitro Model SK-N-BE(2) CVCL_0528 Neuroblastoma Homo sapiens
IMR-32 CVCL_0346 Neuroblastoma Homo sapiens
                    Experimental
                    Result(s)
Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
References
Reference 1 Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Res. 2012 May 15;1454:1-13.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China